Minaris Advanced Therapies
Ilya Koltover is an accomplished executive with extensive experience in the biopharmaceutical and life sciences industries. Currently serving as Chief Transformation Officer at Minaris Advanced Therapies, Ilya leads initiatives to align business operations with strategic objectives. Previously, Ilya was Chief Commercial Officer at Solvias, where a global commercial organization was established, resulting in significant business growth. Ilya’s career includes leadership roles at MilliporeSigma, Merck Life Science, and Sigma-Aldrich, focusing on strategy, commercial operations, and business development. Ilya's academic background includes advanced degrees in Physics and Bioengineering from prestigious institutions, including the University of Wisconsin and Caltech.
This person is not in any teams
This person is not in any offices
Minaris Advanced Therapies
1 followers
Minaris Advanced Therapies is a global contract development and manufacturing organization (CDMO) and contract testing provider focused exclusively on cell and gene therapies. Minaris Advanced Therapies is headquartered in Philadelphia, Pennsylvania, and has more than 730,000 square feet of infrastructure across the United States, Europe and Asia. We have manufactured and released over 7,500 GMP batches and our global network supports therapy developers through early-stage development, clinical trials and commercial manufacturing. By combining scientific expertise with best-in-class manufacturing and testing services, we help bring safe, effective therapies to patients faster and more efficiently. With more than 20 years’ experience in the field of regenerative medicine, we are trusted partner ensuring scalability, delivering high quality results, and achieving cost effective manufacturing. Our state-of-the-art facilities in the United States, Europe, and Asia, as well as our committed employees, enable us to supply patients worldwide with lifechanging therapies. Minaris Advanced Therapies is wholly owned by Altaris, LLC.